Global Cell Therapy Market Size, Status and Forecast 2020-2026

May 2020 | 134 pages | ID: G0F113E03D9CEN
QYResearch

Abstracts

This report focuses on the global Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Dendreon
• Mesoblast
• Vericel
• Novartis AG
• GlaxoSmithKline plc
• MEDIPOST
• Osiris
• PHARMICELL
• NuVasive, Inc.
• JCR Pharmaceuticals Co., Ltd
• ANTEROGEN.CO.,LTD.
• Cynata
• CELLECTIS
• BioNTech IMFS
• EUFETS GmbH
• Cognate
• Pluristem
• Grupo Praxis
• Genzyme Corporation
• Advanced Tissue

Market segment by Type, the product can be split into

• Autologous
• Allogeneic

Market segment by Application, split into

• Hospitals and clinics
• ASCs
• Regenerative medicine centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cell Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cell Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Autologous
  1.4.3 Allogeneic
1.5 Market by Application
  1.5.1 Global Cell Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and clinics
  1.5.3 ASCs
  1.5.4 Regenerative medicine centers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cell Therapy Market Perspective (2015-2026)
2.2 Cell Therapy Growth Trends by Regions
  2.2.1 Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cell Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cell Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Cell Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cell Therapy Players by Market Size
  3.1.1 Global Top Cell Therapy Players by Revenue (2015-2020)
  3.1.2 Global Cell Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cell Therapy Market Concentration Ratio
  3.2.1 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cell Therapy Revenue in 2019
3.3 Cell Therapy Key Players Head office and Area Served
3.4 Key Players Cell Therapy Product Solution and Service
3.5 Date of Enter into Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Cell Therapy Forecasted Market Size by Type (2021-2026)

5 CELL THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cell Therapy Market Size by Application (2015-2020)
5.2 Global Cell Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cell Therapy Market Size (2015-2020)
6.2 Cell Therapy Key Players in North America (2019-2020)
6.3 North America Cell Therapy Market Size by Type (2015-2020)
6.4 North America Cell Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cell Therapy Market Size (2015-2020)
7.2 Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Cell Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Cell Therapy Market Size (2015-2020)
8.2 Cell Therapy Key Players in China (2019-2020)
8.3 China Cell Therapy Market Size by Type (2015-2020)
8.4 China Cell Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cell Therapy Market Size (2015-2020)
9.2 Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Cell Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cell Therapy Market Size (2015-2020)
10.2 Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Cell Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Cell Therapy Market Size (2015-2020)
11.2 Cell Therapy Key Players in India (2019-2020)
11.3 India Cell Therapy Market Size by Type (2015-2020)
11.4 India Cell Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cell Therapy Market Size (2015-2020)
12.2 Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Cell Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Dendreon
  13.1.1 Dendreon Company Details
  13.1.2 Dendreon Business Overview and Its Total Revenue
  13.1.3 Dendreon Cell Therapy Introduction
  13.1.4 Dendreon Revenue in Cell Therapy Business (2015-2020))
  13.1.5 Dendreon Recent Development
13.2 Mesoblast
  13.2.1 Mesoblast Company Details
  13.2.2 Mesoblast Business Overview and Its Total Revenue
  13.2.3 Mesoblast Cell Therapy Introduction
  13.2.4 Mesoblast Revenue in Cell Therapy Business (2015-2020)
  13.2.5 Mesoblast Recent Development
13.3 Vericel
  13.3.1 Vericel Company Details
  13.3.2 Vericel Business Overview and Its Total Revenue
  13.3.3 Vericel Cell Therapy Introduction
  13.3.4 Vericel Revenue in Cell Therapy Business (2015-2020)
  13.3.5 Vericel Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Cell Therapy Introduction
  13.4.4 Novartis AG Revenue in Cell Therapy Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 GlaxoSmithKline plc
  13.5.1 GlaxoSmithKline plc Company Details
  13.5.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline plc Cell Therapy Introduction
  13.5.4 GlaxoSmithKline plc Revenue in Cell Therapy Business (2015-2020)
  13.5.5 GlaxoSmithKline plc Recent Development
13.6 MEDIPOST
  13.6.1 MEDIPOST Company Details
  13.6.2 MEDIPOST Business Overview and Its Total Revenue
  13.6.3 MEDIPOST Cell Therapy Introduction
  13.6.4 MEDIPOST Revenue in Cell Therapy Business (2015-2020)
  13.6.5 MEDIPOST Recent Development
13.7 Osiris
  13.7.1 Osiris Company Details
  13.7.2 Osiris Business Overview and Its Total Revenue
  13.7.3 Osiris Cell Therapy Introduction
  13.7.4 Osiris Revenue in Cell Therapy Business (2015-2020)
  13.7.5 Osiris Recent Development
13.8 PHARMICELL
  13.8.1 PHARMICELL Company Details
  13.8.2 PHARMICELL Business Overview and Its Total Revenue
  13.8.3 PHARMICELL Cell Therapy Introduction
  13.8.4 PHARMICELL Revenue in Cell Therapy Business (2015-2020)
  13.8.5 PHARMICELL Recent Development
13.9 NuVasive, Inc.
  13.9.1 NuVasive, Inc. Company Details
  13.9.2 NuVasive, Inc. Business Overview and Its Total Revenue
  13.9.3 NuVasive, Inc. Cell Therapy Introduction
  13.9.4 NuVasive, Inc. Revenue in Cell Therapy Business (2015-2020)
  13.9.5 NuVasive, Inc. Recent Development
13.10 JCR Pharmaceuticals Co., Ltd
  13.10.1 JCR Pharmaceuticals Co., Ltd Company Details
  13.10.2 JCR Pharmaceuticals Co., Ltd Business Overview and Its Total Revenue
  13.10.3 JCR Pharmaceuticals Co., Ltd Cell Therapy Introduction
  13.10.4 JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2015-2020)
  13.10.5 JCR Pharmaceuticals Co., Ltd Recent Development
13.11 ANTEROGEN.CO.,LTD.
  10.11.1 ANTEROGEN.CO.,LTD. Company Details
  10.11.2 ANTEROGEN.CO.,LTD. Business Overview and Its Total Revenue
  10.11.3 ANTEROGEN.CO.,LTD. Cell Therapy Introduction
  10.11.4 ANTEROGEN.CO.,LTD. Revenue in Cell Therapy Business (2015-2020)
  10.11.5 ANTEROGEN.CO.,LTD. Recent Development
13.12 Cynata
  10.12.1 Cynata Company Details
  10.12.2 Cynata Business Overview and Its Total Revenue
  10.12.3 Cynata Cell Therapy Introduction
  10.12.4 Cynata Revenue in Cell Therapy Business (2015-2020)
  10.12.5 Cynata Recent Development
13.13 CELLECTIS
  10.13.1 CELLECTIS Company Details
  10.13.2 CELLECTIS Business Overview and Its Total Revenue
  10.13.3 CELLECTIS Cell Therapy Introduction
  10.13.4 CELLECTIS Revenue in Cell Therapy Business (2015-2020)
  10.13.5 CELLECTIS Recent Development
13.14 BioNTech IMFS
  10.14.1 BioNTech IMFS Company Details
  10.14.2 BioNTech IMFS Business Overview and Its Total Revenue
  10.14.3 BioNTech IMFS Cell Therapy Introduction
  10.14.4 BioNTech IMFS Revenue in Cell Therapy Business (2015-2020)
  10.14.5 BioNTech IMFS Recent Development
13.15 EUFETS GmbH
  10.15.1 EUFETS GmbH Company Details
  10.15.2 EUFETS GmbH Business Overview and Its Total Revenue
  10.15.3 EUFETS GmbH Cell Therapy Introduction
  10.15.4 EUFETS GmbH Revenue in Cell Therapy Business (2015-2020)
  10.15.5 EUFETS GmbH Recent Development
13.16 Cognate
  10.16.1 Cognate Company Details
  10.16.2 Cognate Business Overview and Its Total Revenue
  10.16.3 Cognate Cell Therapy Introduction
  10.16.4 Cognate Revenue in Cell Therapy Business (2015-2020)
  10.16.5 Cognate Recent Development
13.17 Pluristem
  10.17.1 Pluristem Company Details
  10.17.2 Pluristem Business Overview and Its Total Revenue
  10.17.3 Pluristem Cell Therapy Introduction
  10.17.4 Pluristem Revenue in Cell Therapy Business (2015-2020)
  10.17.5 Pluristem Recent Development
13.18 Grupo Praxis
  10.18.1 Grupo Praxis Company Details
  10.18.2 Grupo Praxis Business Overview and Its Total Revenue
  10.18.3 Grupo Praxis Cell Therapy Introduction
  10.18.4 Grupo Praxis Revenue in Cell Therapy Business (2015-2020)
  10.18.5 Grupo Praxis Recent Development
13.19 Genzyme Corporation
  10.19.1 Genzyme Corporation Company Details
  10.19.2 Genzyme Corporation Business Overview and Its Total Revenue
  10.19.3 Genzyme Corporation Cell Therapy Introduction
  10.19.4 Genzyme Corporation Revenue in Cell Therapy Business (2015-2020)
  10.19.5 Genzyme Corporation Recent Development
13.20 Advanced Tissue
  10.20.1 Advanced Tissue Company Details
  10.20.2 Advanced Tissue Business Overview and Its Total Revenue
  10.20.3 Advanced Tissue Cell Therapy Introduction
  10.20.4 Advanced Tissue Revenue in Cell Therapy Business (2015-2020)
  10.20.5 Advanced Tissue Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Cell Therapy Revenue
Table 3. Ranking of Global Top Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autologous
Table 6. Key Players of Allogeneic
Table 7. Global Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cell Therapy Market Share by Regions (2015-2020)
Table 11. Global Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cell Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cell Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Cell Therapy Players
Table 18. Global Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cell Therapy Market Share by Players (2015-2020)
Table 20. Global Top Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy as of 2019)
Table 21. Global Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell Therapy Product Solution and Service
Table 24. Date of Enter into Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cell Therapy Market Size Share by Type (2015-2020)
Table 28. Global Cell Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Cell Therapy Market Size Share by Application (2015-2020)
Table 30. Global Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cell Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cell Therapy Market Share (2019-2020)
Table 34. North America Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cell Therapy Market Share by Type (2015-2020)
Table 36. North America Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cell Therapy Market Share (2019-2020)
Table 40. Europe Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cell Therapy Market Share by Type (2015-2020)
Table 42. Europe Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cell Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cell Therapy Market Share (2019-2020)
Table 46. China Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Cell Therapy Market Share by Type (2015-2020)
Table 48. China Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Cell Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cell Therapy Market Share (2019-2020)
Table 52. Japan Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cell Therapy Market Share by Type (2015-2020)
Table 54. Japan Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cell Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cell Therapy Market Share (2019-2020)
Table 58. Southeast Asia Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cell Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cell Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cell Therapy Market Share (2019-2020)
Table 64. India Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Cell Therapy Market Share by Type (2015-2020)
Table 66. India Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Cell Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cell Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cell Therapy Market Share (2019-2020)
Table 70. Central & South America Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cell Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cell Therapy Market Share by Application (2015-2020)
Table 74. Dendreon Company Details
Table 75. Dendreon Business Overview
Table 76. Dendreon Product
Table 77. Dendreon Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 78. Dendreon Recent Development
Table 79. Mesoblast Company Details
Table 80. Mesoblast Business Overview
Table 81. Mesoblast Product
Table 82. Mesoblast Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 83. Mesoblast Recent Development
Table 84. Vericel Company Details
Table 85. Vericel Business Overview
Table 86. Vericel Product
Table 87. Vericel Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 88. Vericel Recent Development
Table 89. Novartis AG Company Details
Table 90. Novartis AG Business Overview
Table 91. Novartis AG Product
Table 92. Novartis AG Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 93. Novartis AG Recent Development
Table 94. GlaxoSmithKline plc Company Details
Table 95. GlaxoSmithKline plc Business Overview
Table 96. GlaxoSmithKline plc Product
Table 97. GlaxoSmithKline plc Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline plc Recent Development
Table 99. MEDIPOST Company Details
Table 100. MEDIPOST Business Overview
Table 101. MEDIPOST Product
Table 102. MEDIPOST Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 103. MEDIPOST Recent Development
Table 104. Osiris Company Details
Table 105. Osiris Business Overview
Table 106. Osiris Product
Table 107. Osiris Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 108. Osiris Recent Development
Table 109. PHARMICELL Business Overview
Table 110. PHARMICELL Product
Table 111. PHARMICELL Company Details
Table 112. PHARMICELL Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 113. PHARMICELL Recent Development
Table 114. NuVasive, Inc. Company Details
Table 115. NuVasive, Inc. Business Overview
Table 116. NuVasive, Inc. Product
Table 117. NuVasive, Inc. Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 118. NuVasive, Inc. Recent Development
Table 119. JCR Pharmaceuticals Co., Ltd Company Details
Table 120. JCR Pharmaceuticals Co., Ltd Business Overview
Table 121. JCR Pharmaceuticals Co., Ltd Product
Table 122. JCR Pharmaceuticals Co., Ltd Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 123. JCR Pharmaceuticals Co., Ltd Recent Development
Table 124. ANTEROGEN.CO.,LTD. Company Details
Table 125. ANTEROGEN.CO.,LTD. Business Overview
Table 126. ANTEROGEN.CO.,LTD. Product
Table 127. ANTEROGEN.CO.,LTD. Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 128. ANTEROGEN.CO.,LTD. Recent Development
Table 129. Cynata Company Details
Table 130. Cynata Business Overview
Table 131. Cynata Product
Table 132. Cynata Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 133. Cynata Recent Development
Table 134. CELLECTIS Company Details
Table 135. CELLECTIS Business Overview
Table 136. CELLECTIS Product
Table 137. CELLECTIS Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 138. CELLECTIS Recent Development
Table 139. BioNTech IMFS Company Details
Table 140. BioNTech IMFS Business Overview
Table 141. BioNTech IMFS Product
Table 142. BioNTech IMFS Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 143. BioNTech IMFS Recent Development
Table 144. EUFETS GmbH Company Details
Table 145. EUFETS GmbH Business Overview
Table 146. EUFETS GmbH Product
Table 147. EUFETS GmbH Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 148. EUFETS GmbH Recent Development
Table 149. Cognate Company Details
Table 150. Cognate Business Overview
Table 151. Cognate Product
Table 152. Cognate Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 153. Cognate Recent Development
Table 154. Pluristem Company Details
Table 155. Pluristem Business Overview
Table 156. Pluristem Product
Table 157. Pluristem Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 158. Pluristem Recent Development
Table 159. Grupo Praxis Company Details
Table 160. Grupo Praxis Business Overview
Table 161. Grupo Praxis Product
Table 162. Grupo Praxis Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 163. Grupo Praxis Recent Development
Table 164. Genzyme Corporation Company Details
Table 165. Genzyme Corporation Business Overview
Table 166. Genzyme Corporation Product
Table 167. Genzyme Corporation Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 168. Genzyme Corporation Recent Development
Table 169. Advanced Tissue Company Details
Table 170. Advanced Tissue Business Overview
Table 171. Advanced Tissue Product
Table 172. Advanced Tissue Revenue in Cell Therapy Business (2015-2020) (Million US$)
Table 173. Advanced Tissue Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Autologous Features
Figure 3. Allogeneic Features
Figure 4. Global Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and clinics Case Studies
Figure 6. ASCs Case Studies
Figure 7. Regenerative medicine centers Case Studies
Figure 8. Cell Therapy Report Years Considered
Figure 9. Global Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Cell Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Cell Therapy Market Share by Players in 2019
Figure 14. Global Top Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cell Therapy Revenue in 2019
Figure 16. North America Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Dendreon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Dendreon Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 25. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Mesoblast Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 27. Vericel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Vericel Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 29. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis AG Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 31. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GlaxoSmithKline plc Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 33. MEDIPOST Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. MEDIPOST Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 35. Osiris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Osiris Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 37. PHARMICELL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. PHARMICELL Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 39. NuVasive, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. NuVasive, Inc. Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 41. JCR Pharmaceuticals Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. JCR Pharmaceuticals Co., Ltd Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 43. ANTEROGEN.CO.,LTD. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. ANTEROGEN.CO.,LTD. Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 45. Cynata Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Cynata Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 47. CELLECTIS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. CELLECTIS Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 49. BioNTech IMFS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. BioNTech IMFS Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 51. EUFETS GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. EUFETS GmbH Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 53. Cognate Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Cognate Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 55. Pluristem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Pluristem Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 57. Grupo Praxis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Grupo Praxis Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 59. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Genzyme Corporation Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 61. Advanced Tissue Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Advanced Tissue Revenue Growth Rate in Cell Therapy Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed